Skip to content

Medicated table salt for control of filariasis in endemic areas

Effectiveness and acceptability of DEC iodine fortified salt as an adjunct tool for MDA for elimination of lymphatic filariasis A community based study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094790
Enrollment
160000
Registered
2025-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B740- Filariasis due to Wuchereria bancrofti

Interventions

Intervention1: DEC iodine fortified salt: In the intervention arm, double-fortified salt containing DEC (0.2% w/w) and iodine will be administered for a year along with the routine MDA. In the compara

Sponsors

Vector Control Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All individuals living in the study sites

Exclusion criteria

Exclusion criteria: Persons who are not living in the area for atleast 6 months proceeding to the study time

Design outcomes

Primary

MeasureTime frame
1.Effectiveness of DEC iodine-fortified salt in reducing LF infection to achieve elimination of LF in comparison to the MDA-DA/IDA intervention 2. Operational feasibility and community acceptability of the DEC iodine-fortified salt Timepoint: one year

Secondary

MeasureTime frame
1. The safety of DEC iodine-fortified salt in pregnant women, lactating mothers, and young children 2. The effects of high temperature, humidity, and light exposure for optimal storage and develop an implementation strategy including quality control and delivery of DEC iodine fortified salt to the LF endemic communities for the elimination of LF in IndiaTimepoint: 6 months- safety of DEC iodine fortified salt in pregnant women, lactating mother and young children 12 months- Optimal conditions for the storage of DEC iodine fortified salt for operational purpose

Countries

India

Contacts

Public ContactDr Anoop C Choolayil

ICMR-Vector Control Research Centre

vijeshvcrc.icmr@gmail.com914132272396

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026